Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database
Top Cited Papers
- 10 December 2007
- journal article
- thoracic oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (35) , 5570-5577
- https://doi.org/10.1200/jco.2007.12.5435
Abstract
Purpose: To study the burden and outcome of lung cancer in the elderly, particularly for patients aged 80 years and older. Patients and Methods: The national Surveillance, Epidemiology, and End Results database was analyzed for lung cancer outcomes during the period 1988 to 2003. A comparison was carried out between patients with lung cancer 80 years and older, 70 to 79 years, and younger than 70 years for demographics; stage distribution; 5-year relative survival; and survival based on histology, sex, race, stage, and treatment. The temporal trends in survival during the years 1988 to 1997 and 1998 to 2003 were also analyzed. Results: Of 316,682 patients eligible for the analysis, 45,912 (14%) were 80 years or older (ie, very elderly); 103,963 (33%) were 70 to 79 years; and 166,807 (53%) were younger than 70 years. The distribution by stage and histology was comparable for all the three groups. Overall survival rate at 5 years was lower in the very elderly (7.4% v 12.3% v 15.5%; P < .0001) across sex, histologic subtypes, stages, and racial categories. Patients aged 80 years or older were less likely to receive local therapy (no surgery or radiation) than younger patients (47% v 28% and 19% for the age subgroups ≥ 80 years, 70 to 79 years, and < 70 years, respectively). Overall outcomes for patients who underwent surgical therapy or radiation were comparable across the three age groups. In general, survival outcomes for the subgroup aged 70 to 79 years were similar to those of the subgroup aged 80 years and older who received single modality local therapy. Conclusion: Patients 80 years or older account for 14% (70 years or older accounted for 47%) of all lung cancers, are less likely to be subjected to surgery or radiation, and have inferior outcomes when compared with younger patients.Keywords
This publication has 35 references indexed in Scilit:
- Lung cancer surgery: the first 60 days.☆A population-based studyEuropean Journal of Cardio-Thoracic Surgery, 2006
- Increasing underrepresentation of elderly patients with advanced colorectal or non‐small‐cell lung cancer in chemotherapy trialsInternal Medicine Journal, 2006
- Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment GroupJournal of Clinical Oncology, 2005
- Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of ageEuropean Journal of Cardio-Thoracic Surgery, 2005
- 65+ in the United States: 2005Published by Test accounts ,2005
- Surgical Resection for Lung Cancer in the OctogenarianChest, 2004
- Participation in Cancer Clinical TrialsJAMA, 2004
- Aging Biology and Geriatric Clinical PharmacologyPharmacological Reviews, 2004
- Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burdenCancer, 2002
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999